IgA Nephropathy (IgAN) is a primary glomerulonephritis problem worldwide that develops
mainly in the 2nd and 3rd decade of life and reaches end-stage kidney disease after 20 …

Background: IgA nephropathy, a frequent cause of end-stage renal disease, is an
autoimmune disease wherein immune complexes consisting of IgA1 with galactose-deficient …

IgA nephropathy (IgAN) is the most prevalent primary glomerulonephritis worldwide, with
diverse clinical manifestations characterized by recurrent gross hematuria or microscopic …

On September 27–29, 2018, the International Symposium on IgA Nephropathy, organized
by the International IgA Nephropathy Network, was held in Buenos Aires, Argentina …

IgA nephropathy (IgAN) is the commonest pattern of glomerulonephritis (GN) seen in the
Western world. Of these patients 15–25% develop end-stage renal disease (ESRD) …

IgA nephropathy (IgAn), defined by the pre dominant de position of IgA in the glomerular
mesangium, is the most common form of GN throughout the world. However, its incidence …

IgA nephropathy (IgAN) is the most common primary glomerulonephritis, frequently leading
to end-stage renal disease, as there is no disease-specific therapy. IgAN is diagnosed from …

IgA nephropathy (IgAN), the most common GN worldwide, is characterized by circulating
galactose-deficient IgA (gd-IgA) that forms immune complexes. The immune complexes are …

On May 26–28, 2009, an international symposium on IgA nephropathy was convened in
Stresa, Italy, as a Satellite Symposium of the World Congress of Nephrology held in Milan …

IgA nephropathy (IgAN) represents the leading cause of kidney failure among East Asian
populations and the most frequent form of primary glomerulonephritis among Europeans …